Flat lay with different pills in blister packaging and boxes and on color background, representing ERISA Lawsuit

ERISA Lawsuit Filed Against Johnson & Johnson for Prescription Drug Fraud & Mismanagement of Employee Benefit Program

ERISA Lawsuit for Johnson & Johnson On February 5, 2024, a prescription drug fraud complaint was filed against Johnson & Johnson, as well as the company’s benefits committee for allegedly mismanaging its employee prescription drug benefit program. The case is a proposed class action filed in federal court by Johnson & Johnson’s Health Care Policy...

Prescription pill bottle wrapped in money, representing prescription drug fraud

Centene & Pharmacy Benefit Manager Agree to Pay $215 Million to Settle Prescription Drug Fraud Scheme Allegations

On February 8, 2023, California Attorney General Rob Bonta announced that Centene Corporation agreed to pay $215 million to settle allegations that the company and its Pharmacy Benefit Manager violated the California False Claims Act by committing prescription drug fraud against Medi-Cal. Specifically, the California Department of Justice alleged that Centene submitted false reports of...

Indiana Files PBM Fraud Case Against 6 PBMs and Drug Manufacturers for Inflating Insulin Prices

Indiana PBM Fraud On March 22, 2024, the Indiana Attorney General, Todd Rokita, announced that he is filing a suit against Pharmacy Benefit Managers (PBMs) and drug manufacturers for their part in raising the price of Insulin. This drug manufacturer and PBM fraud lawsuit follows multiple actions filed by other states on the same subject...

Robot sitting in a courtroom, representation of AI Fraud

Investment Advisors Pay $400,000 in Civil Penalties to Settle AI Fraud Case

On March 18, 2024, Delphia Inc. and Global Predictions Inc. paid $400,000 in civil penalties to settle SEC charges related to the two investment advisers misrepresenting the method by which they used artificial intelligence (AI) to support their efforts. The firms were each found to be in violation of the Advisers Act and the SEC‘s...

Digital legal scale representing Crypto Fraud Lawyers

SEC Charges CryptoFX for $300 Million Ponzi Scheme

On March 14, 2024, the Securities and Exchange Commission (SEC) and their crypto fraud lawyer team charged 17 CryptoFX employees for allegedly carrying out a $300 million Ponzi scheme that focused on defrauding the Latino community and impacted more than 40,000 investors. These charges came after the SEC had already issued an emergency action in...

Pills on money with a gavel, representing Big Pharma Opioid

Young Law Group Achieves $475 Million Settlement with Big Pharma Opioid Company

On February 28, 2024, opioid manufacturer, Endo Health Solutions Inc. (“Endo”), agreed to pay $475 million to settle U.S. v. Endo Int’l plc, Case No. 19-cv-80574, a qui tam action brought by an anonymous whistleblower, who Young Law Group represented, on behalf of the United States. The complaint alleged that the company had violated the...

zoomed out view of colorful shipping containers

Yakima Pays $3 Million After Ignoring Fair Trade Practice Rules & Violating the False Claims Act

On January 31, 2024, the United States Attorney’s Office of the Western District of Washington announced that Yakima Products, Inc. agreed to pay $3 million to settle allegations that the company violated the False Claims Act (FCA). Specifically, a former employee brought forth this case under the qui tam provision of the FCA alleging that...

Rendering of a gavel on top of a motherboard, representing settlement in Booz Allen whistleblower case

Booz Allen Whistleblower Case Settled for $377.45 Million

Booz Allen Whistleblower Case: Uncovering Government Overcharging On July 21, 2023, Booz Allen Hamilton Holding Corporation (Booz Allen) agreed to pay $377.45 million to settle claims that the company billed the government and thus used taxpayer dollars for costs associated with non-government related work. The settlement in this Booz Allen whistleblower case is notably one...

The Supreme Court against a blue sky with clouds, representing the supreme court whistleblower

Big Supreme Court Whistleblower Ruling Redefines Retaliation Claims

On February 8, 2024, a Supreme Court whistleblower decision was issued on Murray v. UBS Securities, LLC, No. 22-660, siding with the whistleblower, Trevor Murray, and rejecting the Second Circuit’s assertion that a whistleblower needs to demonstrate that their employer had “retaliatory intent” to receive protections under the Sarbanes Oxley Act. The Sarbanes Oxley Act...

JP Morgan Penalized $18 Million by Whistleblower Securities and Exchange Commission for Violating Protection Law

On January 16, 2024, The Whistleblower Securities and Exchange Commission (SEC) reported that JP Morgan agreed to pay 18 million dollars in order to settle charges brought against them for interfering with brokerage customers and advisory clients’ ability to act as whistleblowers and inform the SEC of possible securities law violations. Specifically, from March 2020...

Author: Anjali Miller